treatment-naive patients with lymphoma
HBsAg negative/HBcAb positive/hepatitis B virus DNA negative at baseline
treated with chemotherapy and/or immunosuppressive therapy
life expectancy of more than 3 months

NCT01765231_inc_T1
Observation
treatment-naive
NCT01765231_inc_T2
Condition
lymphoma
NCT01765231_inc_T3
Measurement
HBsAg
NCT01765231_inc_T4
Value
negative
NCT01765231_inc_T5
Measurement
HBcAb
NCT01765231_inc_T6
Value
positive
NCT01765231_inc_T7
Measurement
hepatitis B virus DNA
NCT01765231_inc_T8
Value
negative
NCT01765231_inc_T9
Temporal
at baseline
NCT01765231_inc_T10
Scope
HBsAg negative/HBcAb positive/hepatitis B virus DNA negative
NCT01765231_inc_T11
Procedure
chemotherapy
NCT01765231_inc_T12
Procedure
immunosuppressive therapy
NCT01765231_inc_T13
Observation
life expectancy
NCT01765231_inc_T14
Temporal
more than 3 months